Baby drug dose mystery: study aims to fix muscle relaxant reversal for infants
NCT ID NCT07477132
First seen Mar 20, 2026 · Last updated May 22, 2026 · Updated 11 times
Summary
This study aims to find the correct dose of sugammadex, a drug that reverses muscle relaxants, for infants younger than 2 years old. Currently, doctors use the same dose as for adults, which may not be safe or effective for babies. The study will test different doses in 99 infants to determine the best amount for complete and safe reversal.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CURARIZATION, POSTOPERATIVE RESIDUAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Hospitalier universitaire Caen Normandie
Caen, 14000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.